上海全新政策支持新冠病毒疫苗进口,mRNA新冠疫苗复必泰有望国内审批上市?

2022-03-29 网络 网络

3月29日,上海发布《上海市全力抗疫情助企业促发展的若干政策措施》。

3月29日,上海发布《上海市全力抗疫情助企业促发展的若干政策措施》。

图片

在保障疫情期间城市有序运行方面,措施提出,加强抗疫物资储备和供应保障,持续提升核酸快速检测能力,加强集中隔离房源建设和筹措,支持新冠病毒疫苗和治疗药物进口,引导支持企业参与抗疫应急能力建设,做好后备医疗资源储备。加大防疫数字化转型支撑力度,进一步推动防疫相关信息数据向基层赋能,为更加精准的疫情防控提供支撑。

今日,复星医药(02196)AH股均飙升逾7%,截至全天收盘,A股涨7.76%,报54.03元。H股涨8.26%,报39.300港元。事实上,前几天复星医药就有一轮上涨。

图片

此前复星医药年报披露,截至2月,复必泰(mRNA新冠疫苗)已在港澳台地区累计接种2000万剂,但迄今内地仍未给与复必泰批文。

大家根据政策推论,认为国家药监局有可能审批复必泰上市的可能。

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2083475, encodeId=24b720834e548, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Fri Jan 27 19:43:20 CST 2023, time=2023-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935875, encodeId=4e2519358e566, content=<a href='/topic/show?id=3c1a4614e9a' target=_blank style='color:#2F92EE;'>#审批上市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46147, encryptionId=3c1a4614e9a, topicName=审批上市)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/17F844FBE270B8196CB4C53EC9493C57/100, createdBy=9d712500079, createdName=ms5906905816781247, createdTime=Mon Aug 08 04:43:20 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260524, encodeId=47751260524bf, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Thu Mar 31 13:43:20 CST 2022, time=2022-03-31, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2083475, encodeId=24b720834e548, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Fri Jan 27 19:43:20 CST 2023, time=2023-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935875, encodeId=4e2519358e566, content=<a href='/topic/show?id=3c1a4614e9a' target=_blank style='color:#2F92EE;'>#审批上市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46147, encryptionId=3c1a4614e9a, topicName=审批上市)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/17F844FBE270B8196CB4C53EC9493C57/100, createdBy=9d712500079, createdName=ms5906905816781247, createdTime=Mon Aug 08 04:43:20 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260524, encodeId=47751260524bf, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Thu Mar 31 13:43:20 CST 2022, time=2022-03-31, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2083475, encodeId=24b720834e548, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Fri Jan 27 19:43:20 CST 2023, time=2023-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935875, encodeId=4e2519358e566, content=<a href='/topic/show?id=3c1a4614e9a' target=_blank style='color:#2F92EE;'>#审批上市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46147, encryptionId=3c1a4614e9a, topicName=审批上市)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/17F844FBE270B8196CB4C53EC9493C57/100, createdBy=9d712500079, createdName=ms5906905816781247, createdTime=Mon Aug 08 04:43:20 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260524, encodeId=47751260524bf, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Thu Mar 31 13:43:20 CST 2022, time=2022-03-31, status=1, ipAttribution=)]
    2022-03-31 bioon3

相关威廉亚洲官网

港澳将于下周一重启接种复星新冠疫苗复必泰

港府宣布4月5日恢复该款疫苗接种,疫苗包装封口在超低温环境下时出现密封性问题,但不影响疫苗质量。